Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
Is a |
Product containing amylase (medicinal product) |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amylase (substance) |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
A substance containing enzymes, mainly lipase, with amylase and protease, obtained from the pancreas of the hog. It is a cream-coloured, amorphous powder having a faint characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancrelipase contains, in each mg, not less than 24 USP units of lipase activity, not less than 100 USP units of amylase activity, and not less than 100 USP units of protease activity. |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
Is a |
amylase + lipase + protease |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with protease mechanism of action |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lipase |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Triacylglycerol lipase |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
Has manufactured dose form |
Oral tablet |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Endopeptidase (substance) |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|
amylase + pancreaslipase + pancreasprotease, tablet à 12500 enheder/1000 enheder/12500 enheder |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|